NorthWest Biotherapeutics Inc (NWBO)

[iclight]

You need to quit focusing on sites opening and start focusing on enrollment numbers. The site openings simply cost YOU money.

And quit replying to posts with obscure studies that do nothing to refute a post.

CLDX has 223 sites and has completed enrollment of 700.

So ask yourself THIS question:

Why can't NWBO complete enrollment for L P3?

Also Celldex were able to complete enrollment of 168 patients in their PII for EGFRvlll with only 45 locations and that's only prevalent in 1/3 of GBM patients.

I have no position in CLDX but it shows a company that is competent in creating and enrolling in clinical trials and one who is not.

And before you say "oncologists are not up to speed on DCVax" well that's an NWBO problem, isn't it?